Xeris Biopharma Holdings (XERS)See Remarks sold ~$157K

~$157K

Approx. value · 17K sh @ $9.41

1.11M

Holds after · shares reported

Traded

Oct 1, 2026

Filed

Oct 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
2. Sep 28, 2026InsiderOfficer sold ~$250K of XERS shares in the open market
3. Oct 1, 2026 · this disclosureInsiderOfficer sold ~$157K of XERS shares in the open market

What came next

1. Oct 1, 2026Insider · 2 peopleInsiders: 2 sales (~$188K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Xeris Biopharma Holdings

For Xeris Biopharma Holdings, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its XERS page.

Other recent filings by Beth Hecht, See Remarks

• SEC Form 4 at Xeris Biopharma Holdings (XERS)Mar 21, 2025

The full history of Beth Hecht, See Remarks is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Xeris Biopharma Holdings

• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 29, 2026
• SEC Form 4Sep 12, 2025
• SEC Form 4Aug 29, 2025
• SEC Form 4Aug 15, 2025

Everything OQRO holds on this company is on its XERS page.